JTT-861

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameJTT-861
Drug Alias NameJTT-861
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase inhibitors
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkros Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkros Pharma Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A